Author:
Laustsen Andreas H.,Lomonte Bruno,Lohse Brian,Fernández Julián,Gutiérrez José María
Funder
Department of Drug Design and Pharmacology
University of Copenhagen
Instituto Clodomiro Picado
Universidad de Costa Rica
Drug Research Academy (University of Copenhagen)
Dansk Tennis Fond Oticon Fonden
Knud Højgaards Fond
Rudolph Als Fondet
Henry Shaws Legat
Læge Johannes Nicolai Krigsgaard of Hustru Else Krogsgaards Mindelegat for Medicinsk Forskning og Medicinske Studenter ved Københavns Universitet
Lundbeckfonden
Torben of Alice Frimodts Fond
Frants Allings Legat, Christian og Ottilia Brorsons Rejselegat for Yngre Videnskabsmænd- og kvinder
Fonden for Lægevidenskabens Fremme
Reference54 articles.
1. Chapter 26: clinical toxicology of snakebite in Africa and the Middle East/Arabian peninsula;Warrell,1995
2. “Spice,” “Kryptonite,” “Black Mamba”: an overview of brand names and marketing strategies of novel psychoactive substances on the Web;Corazza;J Psychoactive Drugs,2014
3. Biology and treatment of the mamba snakebite;Hodgson;Wilderness Environ Med,1996
4. WHO guidelines for the production, control and regulation of snake antivenom immunoglobulins;World Health Organization,2010
5. Action of phospholipase A from black mamba (Dendroaspis polylepis) venom on phospholipids of human blood;Ibrahim;Toxicon,1975